Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-01
2011-03-01
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S095000
Reexamination Certificate
active
07897610
ABSTRACT:
The invention relates to the use of benzo[c]quinolizinium derivatives for treating diseases that are linked to smooth muscle cell constriction, such as hypertension and asthma.
REFERENCES:
patent: 6630482 (2003-10-01), Becq et al.
patent: 98/05642 (1998-02-01), None
Becq Frédéric
Joffre Michel
Marivingt-Mounir Cécile
Mettey Yvette
Pignoux Laurence
Aulakh Charanjit S
Centre National de la Recherche Scientifique
Clark & Elbing LLP
Universite de Poitiers
LandOfFree
Use of benzo[c]quinolizinium derivatives for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of benzo[c]quinolizinium derivatives for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of benzo[c]quinolizinium derivatives for the treatment... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2755031